H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report)’s stock price crossed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $22.00 and traded as high as $24.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares.
H. Lundbeck A/S Stock Performance
The company has a quick ratio of 0.71, a current ratio of 1.15 and a debt-to-equity ratio of 0.32. The firm has a 50-day moving average price of $22.00 and a two-hundred day moving average price of $22.00. The firm has a market cap of $21.91 billion, a PE ratio of 25.00 and a beta of 0.68.
H. Lundbeck A/S Company Profile
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.
See Also
- Five stocks we like better than H. Lundbeck A/S
- 3 Stocks to Consider Buying in October
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- Breakout Stocks: What They Are and How to Identify Them
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- What are earnings reports?
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.
